People: Boston Scientific Corp (BSX.N)
21 Nov 2018
Mr. Kevin J. Ballinger is Executive Vice President and Global President - Interventional Cardiology of the Company. In his current role, Mr. Ballinger is responsible for developing and bringing to market innovative solutions that diagnose and treat coronary artery disease and structural heart disorders. Prior to that, he served as senior vice president from January 2013 to February 2017. Mr. Ballinger has more than 20 years of interventional cardiology experience. Prior to his current role, he was also president, interventional cardiology and held a variety of engineering and general management positions within our Interventional Cardiology and Peripheral Interventions business units, including vice president and general manager, group program management, cardiology, rhythm and vascular; vice president of research and development, peripheral interventions and vice president of program management, cardiovascular. Mr. Ballinger earned a B.S. in mechanical engineering from Michigan Technological University and an M.B.A. from the University of Minnesota.
|Total Annual Compensation, USD||889,651|
|Restricted Stock Award, USD||1,316,090|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||602,834|
|Fiscal Year Total, USD||2,808,570|